2jc1: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 12: | Line 12: | ||
===CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223=== | ===CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223=== | ||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_17269759}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 17269759 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_17269759}} | |||
==About this Structure== | ==About this Structure== | ||
2JC1 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JC1 OCA]. | 2JC1 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2JC1 OCA]. | ||
==Reference== | |||
<ref group="xtra">PMID:17269759</ref><references group="xtra"/> | |||
[[Category: Hepatitis c virus]] | [[Category: Hepatitis c virus]] | ||
[[Category: Singh, O M.]] | [[Category: Singh, O M.]] | ||
Line 23: | Line 32: | ||
[[Category: Polymerase]] | [[Category: Polymerase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 22 11:25:13 2009'' |
Revision as of 12:25, 22 March 2009
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223
Template:ABSTRACT PUBMED 17269759
About this StructureAbout this Structure
2JC1 is a 2 chains structure of sequences from Hepatitis c virus. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Slater MJ, Amphlett EM, Andrews DM, Bravi G, Burton G, Cheasty AG, Corfield JA, Ellis MR, Fenwick RH, Fernandes S, Guidetti R, Haigh D, Hartley CD, Howes PD, Jackson DL, Jarvest RL, Lovegrove VL, Medhurst KJ, Parry NR, Price H, Shah P, Singh OM, Stocker R, Thommes P, Wilkinson C, Wonacott A. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate. J Med Chem. 2007 Mar 8;50(5):897-900. Epub 2007 Feb 2. PMID:17269759 doi:10.1021/jm061207r
Page seeded by OCA on Sun Mar 22 11:25:13 2009